Singapore markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
149.60+1.17 (+0.79%)
As of 10:17AM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
812,688
866,394
819,975
496,580
-
Other short-term investments
1,626,694
1,326,012
1,615,589
1,377,815
-
Total cash
2,439,382
2,192,406
2,435,564
1,874,395
-
Net receivables
327,787
237,963
198,571
102,413
-
Inventory
89,146
128,962
86,363
75,202
-
Other current assets
126,382
132,916
88,078
62,767
-
Total current assets
2,982,697
2,692,247
2,808,576
2,614,777
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
948,865
912,080
874,048
810,861
-
Accumulated depreciation
-223,076
-173,450
-140,415
-104,347
-
Net property, plant and equipment
725,789
738,630
733,633
706,514
-
Equity and other investments
-
-
-
-
14,825
Other long-term assets
121,394
115,482
101,095
85,770
-
Total non-current assets
847,183
854,112
834,728
792,284
-
Total assets
3,829,880
3,546,359
3,643,304
3,407,061
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
55,519
98,094
73,426
51,966
-
Accrued liabilities
590,843
414,770
301,591
258,476
-
Deferred revenues
102,753
42,105
149,483
127,207
-
Other current liabilities
54,991
40,289
37,079
13,316
-
Total current liabilities
967,786
767,915
695,710
585,270
-
Non-current liabilities
Long-term debt
1,020,776
1,016,942
675,697
191,278
-
Deferred revenues
188,175
193,791
152,360
225,094
-
Other long-term liabilities
1,630,686
1,464,595
1,249,987
1,096,133
-
Total non-current liabilities
3,082,738
2,936,667
2,359,391
1,805,544
-
Total liabilities
4,050,524
3,704,582
3,055,101
2,390,814
-
Stockholders' equity
Common stock
1,259
1,240
1,202
1,164
-
Retained earnings
-7,009,591
-6,569,349
-5,438,193
-4,585,369
-
Accumulated other comprehensive income
-23,375
-44,654
-33,259
-43,622
-
Total stockholders' equity
-220,644
-158,223
588,203
1,016,247
-
Total liabilities and stockholders' equity
3,829,880
3,546,359
3,643,304
3,407,061
-